Maxcyte (MXCT) Intangibles (2025 - 2026)
Maxcyte's (MXCT) quarterly Intangibles came in at $783000.0 in Q1 2026, up 20.46% year-on-year from $650000.0 in Q1 2025, and up 20.46% on a QoQ basis from $650000.0 in Q4 2025.
Maxcyte (MXCT) Intangibles (2025 - 2026) Analysis & Trends
Maxcyte (MXCT) has 2 years of Intangibles data on file, last reported at $783000.0 in Q1 2026.
- On a quarterly basis, Intangibles rose 20.46% year-over-year to $783000.0 in Q1 2026; TTM through Mar 2026 was $783000.0, a 20.46% increase from a year earlier, with the FY2025 full-year figure at $650000.0, changed N/A from the prior year.
- Intangibles for Q1 2026 stood at $783000.0, up from $650000.0 in the prior quarter.
- Over the last five years, Intangibles for MXCT reached as high as $783000.0 in Q1 2026 and fell as low as $638000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 17.88 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 5.52 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 10.15 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 7.06 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.23 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 62.60 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 1.91 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 882.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.14 Bn |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | 783,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 783,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 638,000.00 |
| Mar 31, 2025 | 650,000.00 |